Cutter & CO Brokerage, Inc. Bio N Tech Se Transaction History

Cutter & CO Brokerage, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$126.25 - $231.85 $23,861 - $43,819	-189 Reduced 4.11%	4,408 $752,000
Q4 2021 Feb 10, 2022	SELL	$216.64 - $362.52 $167,896 - $280,953	-775 Reduced 14.43%	4,597 $1.19 Million
Q3 2021 Nov 02, 2021	SELL	$205.93 - $447.23 $223,228 - $484,797	-1,084 Reduced 16.79%	5,372 $1.47 Million
Q3 2020 Nov 05, 2020	SELL	$57.81 - $104.17 $402,877 - $725,960	-6,969 Reduced 51.91%	6,456 $447,000
Q2 2020 Aug 10, 2020	BUY	$38.58 - $66.74 $517,936 - $895,984	13,425 New	13,425 $896,000

360

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.